ADBIOTECH Co.,Ltd. Logo

ADBIOTECH Co.,Ltd.

Develops IgY-based immune antibodies as alternatives to vaccines and antibiotics.

179530 | KO

Overview

Corporate Details

ISIN(s):
KR7179530001
LEI:
Country:
South Korea
Address:
강원도 춘천시 동내면 거두단지1길 39, 춘천시

Description

ADBIOTECH Co., Ltd. is a biotechnology company specializing in the development and commercialization of immune antibodies. The company's core competency is IgY (Immunoglobulin in Yolk) technology, which utilizes antibodies derived from eggs to create alternatives to conventional vaccines and antibiotics. Its product portfolio targets the livestock, aquaculture, and human health sectors, with applications for disease prevention and treatment in animals like salmon and shrimp, as well as human-focused developments for conditions related to Helicobacter pylori and cholesterol. The company manages the entire value chain from research and development to production and sales. ADBIOTECH is also expanding its technological capabilities into VHH (nanobody) technology, with a strategic focus on the global companion animal market.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-09-15 00:00
[기재정정]주주총회소집결의 (임시주주총회)
Korean 31.7 KB
2025-09-15 00:00
주주총회소집공고
Korean 133.2 KB
2025-09-15 00:00
의결권대리행사권유참고서류
Korean 81.3 KB
2025-08-29 00:00
[기재정정]주요사항보고서(유상증자결정)
Korean 68.2 KB
2025-08-29 00:00
[기재정정]경영권변경등에관한계약체결
Korean 17.2 KB
2025-08-22 00:00
[기재정정]주요사항보고서(전환사채권발행결정)
Korean 105.4 KB
2025-08-22 00:00
[기재정정]주요사항보고서(신주인수권부사채권발행결정)
Korean 102.6 KB
2025-08-22 00:00
[기재정정]주요사항보고서(전환사채권발행결정)
Korean 95.8 KB
2025-08-22 00:00
[기재정정]주주총회소집결의 (임시주주총회)
Korean 29.0 KB
2025-08-22 00:00
[기재정정]주주명부폐쇄기간또는기준일설정
Korean 7.6 KB
2025-08-22 00:00
[기재정정]주주총회소집공고
Korean 132.6 KB
2025-08-14 00:00
반기보고서 (2025.06)
Korean 1.6 MB
2025-08-14 00:00
[기재정정]주주총회소집결의 (임시주주총회)
Korean 35.8 KB
2025-08-14 00:00
주주총회소집공고
Korean 129.8 KB
2025-08-14 00:00
의결권대리행사권유참고서류
Korean 81.6 KB

Automate Your Workflow. Get a real-time feed of all ADBIOTECH Co.,Ltd. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for ADBIOTECH Co.,Ltd.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for ADBIOTECH Co.,Ltd. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

4BASEBIO PLC Logo
Manufactures GMP-grade synthetic DNA for next-generation therapeutics and vaccines.
United Kingdom
4BB
4D Molecular Therapeutics, Inc. Logo
Develops genetic medicines using AAV vectors for ophthalmology and pulmonology diseases.
United States of America
FDMT
4SC AG Logo
Biopharmaceutical company with no products under development or operational business.
Germany
VSC
60 DEGREES PHARMACEUTICALS, INC. Logo
Develops and commercializes medicines for infectious diseases, focusing on tropical illnesses.
United States of America
SXTP
89bio, Inc. Logo
Clinical-stage biopharma developing therapies for liver and cardiometabolic diseases.
United States of America
ETNB
Aardvark Therapeutics, Inc. Logo
Clinical-stage biopharma developing therapeutics for hunger and metabolic diseases.
United States of America
AARD
ABBOTT LABORATORIES Logo
Global healthcare company in medical devices, diagnostics, nutrition & pharmaceuticals.
United States of America
ABT
AbbVie Inc. Logo
A research-based biopharmaceutical company developing and manufacturing medicines.
United States of America
ABBV
AbCellera Biologics Inc. Logo
Discovers and develops antibody-based therapeutics using a proprietary platform.
United States of America
ABCL
Develops antibody-based therapeutics using CAR-T, NEST, and AffiMab platforms.
South Korea
174900

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.